Nephron Announces Asthmanefrin™, An Alternative To Primatene® Mist

ORLANDO, Fla., Aug. 21, 2012 /PRNewswire/ -- Nephron Pharmaceuticals Corporation (Nephron) is proud to announce Asthmanefrin, a fast acting, safe and effective over-the-counter (OTC) alternative to the discontinued Primatene® Mist chlorofluorocarbon (CFC) inhaler.

Asthmanefrin will provide relief for millions of former Primatene® Mist users.  The Primatene® Mist CFC inhaler was removed from the market by the Food and Drug Administration (FDA) and the Environmental Protection Agency (EPA) on Dec. 31, 2011.  The inhaler was discontinued because of its CFC propellant.  Asthmanefrin does not contain CFCs or preservatives.  The active ingredient in Asthmanefrin, Racepinephrine, has been safely used by hospitals, pharmacies, and physicians for more than a century.

Starting late August thru the first week of September, Asthmanefrin will be available nationally in Walmart, closely followed by CVS/pharmacy®, and other retail outlets.  The product will be available in a starter kit and a refill package.  The starter kit includes 10 Asthmanefrin vials and the EZ Breathe Atomizer. The refill package will include 30 Asthmanefrin vials.  The EZ Breathe Atomizer is an OTC device that is intended to spray liquid medication in aerosol form into the air that a person will breathe.

Lou Kennedy, CEO, stated, "Until now, there has been no alternative to fill the void left by Primatene® Mist CFC inhaler.  As an industry leader in respiratory medications, introducing Asthmanefrin into the retail market is a natural choice for Nephron.  We are proud to bring this quality, low-cost, OTC medication to the market.  The use of Asthmanefrin, along with the pocket sized EZ Breathe Atomizer, will give bronchial asthma sufferers an excellent alternative treatment to Primatene® Mist, at an affordable price."

For more information about Asthmanefrin, call 1-855-999-EZAN (3926), or visit www.asthmanefrin.com.

Nephron Pharmaceuticals Corp. is a private, woman owned manufacturer of generic inhalation solutions, headquartered in Orlando, Florida, and employs 500 persons nationwide.  Nephron has manufactured billions of doses of life saving medications since 1997.  The company is developing a new facility in Cayce, South Carolina, which will expand its product line to include opthalmic and injectable medications, and provide space for contract manufacturing.

Primatene ® Mist is a registered trademark of Armstrong Pharmaceuticals, Inc.

SOURCE Nephron Pharmaceuticals Corporation